Grimes & Company Inc. raised its stake in shares of Oracle Corporation (NYSE:ORCL – Free Report) by 10.3% in the second quarter, Holdings Channel.com reports. The institutional investor owned 13,546 shares of the enterprise software provider’s stock after buying an additional 1,263 shares during the quarter. Grimes & Company Inc.’s holdings in Oracle were worth $2,962,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. increased its position in Oracle by 2.2% during the first quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock valued at $22,498,982,000 after acquiring an additional 3,513,464 shares during the last quarter. Northern Trust Corp grew its stake in shares of Oracle by 0.6% during the 1st quarter. Northern Trust Corp now owns 19,741,423 shares of the enterprise software provider’s stock valued at $2,760,048,000 after purchasing an additional 120,889 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Oracle by 0.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 13,884,524 shares of the enterprise software provider’s stock valued at $1,941,195,000 after purchasing an additional 59,164 shares during the last quarter. Amundi lifted its stake in shares of Oracle by 3.3% in the 1st quarter. Amundi now owns 12,736,855 shares of the enterprise software provider’s stock worth $1,749,280,000 after purchasing an additional 409,691 shares during the period. Finally, Polen Capital Management LLC boosted its holdings in shares of Oracle by 17.6% in the first quarter. Polen Capital Management LLC now owns 12,609,101 shares of the enterprise software provider’s stock worth $1,762,878,000 after buying an additional 1,885,370 shares during the last quarter. 42.44% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of analysts have commented on the stock. Barclays upped their target price on shares of Oracle from $221.00 to $281.00 and gave the company an “overweight” rating in a report on Monday, September 8th. Cowen reaffirmed a “buy” rating and issued a $375.00 target price on shares of Oracle in a report on Wednesday, September 10th. Roth Capital reiterated a “hold” rating on shares of Oracle in a research report on Wednesday, June 18th. Jefferies Financial Group upped their price target on Oracle from $270.00 to $360.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Finally, Sanford C. Bernstein lifted their price objective on Oracle from $363.00 to $364.00 and gave the company an “outperform” rating in a research report on Friday, September 26th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $304.71.
Oracle Trading Up 2.0%
Shares of ORCL opened at $291.77 on Tuesday. The firm has a market cap of $831.77 billion, a P/E ratio of 67.54, a price-to-earnings-growth ratio of 3.08 and a beta of 1.53. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. Oracle Corporation has a 1 year low of $118.86 and a 1 year high of $345.72. The company has a 50 day simple moving average of $263.41 and a two-hundred day simple moving average of $206.82.
Oracle (NYSE:ORCL – Get Free Report) last issued its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The company had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.Oracle’s revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, equities analysts expect that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be given a dividend of $0.50 per share. The ex-dividend date is Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.7%. Oracle’s dividend payout ratio (DPR) is presently 46.30%.
Insider Transactions at Oracle
In other Oracle news, insider Clayton M. Magouyrk sold 21,241 shares of Oracle stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $297.11, for a total value of $6,310,913.51. Following the sale, the insider owned 78,000 shares of the company’s stock, valued at $23,174,580. The trade was a 21.40% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Michael D. Sicilia sold 33,845 shares of the stock in a transaction that occurred on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total value of $10,869,660.20. Following the transaction, the insider owned 132,656 shares of the company’s stock, valued at $42,603,800.96. This represents a 20.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 104,314 shares of company stock valued at $31,272,223 over the last three months. Corporate insiders own 40.90% of the company’s stock.
About Oracle
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Read More
- Five stocks we like better than Oracle
- Overbought Stocks Explained: Should You Trade Them?
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- What Are Dividend Contenders? Investing in Dividend Contenders
- 3 Exceptional Stocks to Build Long-Term Wealth
- What is a Dividend King?
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.